Pfizer and Mylan Partner for Generics Business in Japan

Pfizer Inc.

and Mylan Inc.

today announced that they have signed a definitive agreement to establish an exclusive long-term strategic collaboration to develop, manufacture, distribute and market generic drugs in Japan. The collaboration is designed to build upon each company's highly complementary strengths and quality assets.